CRYM — Cryomass Technologies Income Statement
0.000.00%
- $6.55m
- $9.69m
- $0.01m
Annual income statement for Cryomass Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.018 | 0.781 | 0 | 0 | 0.014 |
Cost of Revenue | |||||
Gross Profit | -0.181 | 0.037 | 0 | 0 | 0.014 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3.35 | 7.32 | 7.99 | 10.3 | 12.5 |
Operating Profit | -3.33 | -6.53 | -7.99 | -10.3 | -12.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -3.33 | -6.86 | -10.1 | -10.4 | -12.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.34 | -6.86 | -10.1 | -10.4 | -13 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -3.06 | -11.8 | -12.9 | -10.4 | -13 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -3.06 | -11.8 | -12.9 | -10.4 | -13 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | -0.069 | -0.064 | -0.052 | -0.042 |